Mariëtte Labots

3.3k total citations
60 papers, 1.1k citations indexed

About

Mariëtte Labots is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mariëtte Labots has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 25 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Mariëtte Labots's work include Cancer Genomics and Diagnostics (16 papers), Colorectal Cancer Treatments and Studies (13 papers) and Advanced Proteomics Techniques and Applications (9 papers). Mariëtte Labots is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Colorectal Cancer Treatments and Studies (13 papers) and Advanced Proteomics Techniques and Applications (9 papers). Mariëtte Labots collaborates with scholars based in Netherlands, United States and United Kingdom. Mariëtte Labots's co-authors include Henk M.W. Verheul, Henk Dekker, Connie R. Jiménez, Sander R. Piersma, Godefridus J. Peters, Richard J. Honeywell, Henk J. Broxterman, Richard R. de Haas, Kristy J. Gotink and Michelle A. Rudek and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Mariëtte Labots

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mariëtte Labots Netherlands	17	576	457	329	296	127	60	1.1k
Stephanie M. McGregor United States	18	490 0.9×	345 0.8×	245 0.7×	374 1.3×	45 0.4×	52	1.3k
Kimberly N. Johnson United States	10	690 1.2×	1.0k 2.2×	641 1.9×	337 1.1×	99 0.8×	13	1.6k
Jeannine Geneix France	15	962 1.7×	630 1.4×	561 1.7×	126 0.4×	178 1.4×	16	1.6k
Sophia L. Maund United States	13	368 0.6×	360 0.8×	180 0.5×	222 0.8×	195 1.5×	31	815
James B. Smadbeck United States	21	602 1.0×	235 0.5×	201 0.6×	173 0.6×	109 0.9×	74	1.2k
Cecily P. Vaughn United States	16	544 0.9×	539 1.2×	368 1.1×	199 0.7×	473 3.7×	28	1.2k
Veronique Neumeister United States	17	510 0.9×	496 1.1×	319 1.0×	170 0.6×	50 0.4×	35	968
Douglas E. Linn United States	11	847 1.5×	334 0.7×	379 1.2×	953 3.2×	111 0.9×	17	1.5k
Elena Roz Italy	15	808 1.4×	849 1.9×	692 2.1×	463 1.6×	143 1.1×	22	1.8k
Lydia Sánchez Spain	19	642 1.1×	580 1.3×	224 0.7×	93 0.3×	367 2.9×	25	1.3k

Countries citing papers authored by Mariëtte Labots

Since Specialization

Citations

This map shows the geographic impact of Mariëtte Labots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariëtte Labots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariëtte Labots more than expected).

Fields of papers citing papers by Mariëtte Labots

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariëtte Labots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariëtte Labots. The network helps show where Mariëtte Labots may publish in the future.

Co-authorship network of co-authors of Mariëtte Labots

This figure shows the co-authorship network connecting the top 25 collaborators of Mariëtte Labots. A scholar is included among the top collaborators of Mariëtte Labots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariëtte Labots. Mariëtte Labots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosendael, Philippe J. van, et al.. (2026). Immune Checkpoint Inhibitor Myocarditis: When Profound Troponin Elevation Diverges From Unremarkable Imaging. ESC Heart Failure.

Dings, Mark P.G., Jan Köster, Mariëtte Labots, et al.. (2025). KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer. Med. 6(6). 100601–100601. 1 indexed citations

Tsang-A-Sjoe, Michel, George L. Burchell, Gerrit Jansen, et al.. (2025). Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis. Cancer and Metastasis Reviews. 44(1). 35–35. 4 indexed citations

Labots, Mariëtte, et al.. (2024). Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluation. Acta Oncologica. 63. 169–174. 3 indexed citations

Beekhof, Robin, Andrea Bertotti, Franziska Böttger, et al.. (2023). Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer. Science Translational Medicine. 15(709). eabm3687–eabm3687. 17 indexed citations

Wijngaart, Hanneke van der, Henk Dekker, Sander R. Piersma, et al.. (2023). Advancing wide implementation of precision oncology: A liquid nitrogen‐free snap freezer preserves molecular profiles of biological samples. Cancer Medicine. 12(9). 10979–10989. 1 indexed citations

Smid, Marcel, Job van Riet, Lindsay Angus, et al.. (2021). Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. Nature Communications. 12(1). 574–574. 45 indexed citations

Smid, Marcel, Job van Riet, Lindsay Angus, et al.. (2021). Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. Nature Communications. 12(1). 3269–3269. 6 indexed citations

Douma, Joeri A J, Laurien M. Buffart, Ramy Sedhom, et al.. (2021). Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology. Cancers. 13(10). 2304–2304. 4 indexed citations

10.

Buffart, Tineke E., Riet Hilhorst, Hans Pruijt, et al.. (2021). Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients. Clinical Proteomics. 18(1). 8–8. 3 indexed citations

11.

Labots, Mariëtte, Thang V. Pham, Richard J. Honeywell, et al.. (2020). Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome. Cancers. 12(2). 330–330. 12 indexed citations

12.

Hoes, Louisa R., Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, et al.. (2020). 594P The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients. Annals of Oncology. 31. S498–S498. 2 indexed citations

13.

Någård, Mats, Mei-Lin Ah-See, Karen So, et al.. (2020). Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 86(1). 97–108. 8 indexed citations

14.

Beekhof, Robin, Alex A. Henneman, Jaco C. Knol, et al.. (2019). INKA , an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Molecular Systems Biology. 15(4). e8250–e8250. 59 indexed citations

15.

Labots, Mariëtte, Johannes C. van der Mijn, Robin Beekhof, et al.. (2017). Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. Journal of Proteomics. 162. 99–107. 26 indexed citations

16.

Labots, Mariëtte, Kristy J. Gotink, Henk Dekker, et al.. (2016). Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer. Experimental & Molecular Medicine. 48(12). e279–e279. 21 indexed citations

17.

Mijn, Johannes C. van der, Mariëtte Labots, Sander R. Piersma, et al.. (2015). Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics. Journal of Proteomics. 127(Pt B). 259–263. 39 indexed citations

18.

Piersma, Sander R., Jaco C. Knol, Mariëtte Labots, et al.. (2015). Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines. Journal of Proteomics. 127(Pt B). 247–258. 43 indexed citations

19.

Wit, Djoeke de, Nielka P. van Erp, Jan den Hartigh, et al.. (2014). Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib. Therapeutic Drug Monitoring. 37(3). 331–338. 50 indexed citations

20.

Gotink, Kristy J., Henk J. Broxterman, Mariëtte Labots, et al.. (2011). Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance. Clinical Cancer Research. 17(23). 7337–7346. 290 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact